Abstract:BACKGROUND & OBJECTIVE:Studying the mechanism of why the abnormal protein coded by mutant gene of hepatoma carcinoma cell possesses potential antigenicity, but can not form effective immunogen, searching for specific antigen of hepatoma, and developing DNA vaccine for hepatoma treatment will have active impact on the immunotherapy of hepatoma. This study was to construct fluorescent eukaryotic expression vector of mouse alpha fetoprotein (AFP) cDNA fragment with or without the secretory signal peptide (termed AFP1 cDNA and AFP2 cDNA), and observe its expression in mouse dendritic cells (DCs) and in vitro antitumor effect on hepatoma.METHODS:AFP1 cDNA and AFP2 cDNA were amplified from mouse hepatoma cell line H22 by reverse transcription-polymerase chain reaction (RT-PCR), and cloned into eukaryotic expression vector PEGF-N3 to form the recombinant PEGF-N3/AFP1 and PEGF-N3/AFP2. The mouse bone marrow cells were induced with recombinant granulocyte-macrophage colony-stimulating factor (rmGM-CSF) and recombinant interleukin-4 (rmIL-4) to form mature DCs. The recombinant PEGF-N3/AFP1 and PEGF-N3/AFP2 were transfected into DCs. The DCs vaccine were co-cultured with isogenous mouse spleen lymphocytes. The expression of gamma-interferon (IFN-gamma) in the spleen lymphocytes stimulated by AFP1/DCs or AFP2/DCs was measured by ELISA assay; the specific killing activity of cytotoxic T lymphocytes (CTLs) was evaluated by 51Cr release assay.RESULTS:Sequencing analysis verified that AFP1 cDNA and AFP2 cDNA were correctly amplified from H22 cells. The recombinant PEGF-N3/AFP1 and PEGF-N3/AFP2 were stably expressed in mouse DCs. AFP2/DCs obviously stimulated proliferation of T lymphocytes; the stimulation index (SI) was significantly higher in AFP2/DCs group than in AFP1/DCs group, empty vector group, and blank control group (5.12 +/- 1.46 vs. 1.41 +/- 0.65, 1.42 +/- 0.7, and 1.41 +/- 0.55, P < 0.01); the specific killing activity of CTLs was stronger in AFP2/DCs group than in empty vector group [(88.15 +/- 16.4)% vs. (12.72 +/- 5.45)%].CONCLUSION:The recombinant expression vectors PEGF-N3/AFP1 and PEGF-N3/AFP2 with or without signal peptide were constructed successfully. AFP2/DCs can specifically activate T lymphocytes in vitro and effectively induce antitumor immune response.

The construction of human alpha fetoprotein full length gene eukaryotic expressing vector by RT-PCR method

Recombined and Construction of Human Alpha-fetoprotein Eukaryotic Expression Vector Plasmid pEGFP-C1-AFP-TK

Construction and Expression of Recombined Human AFP Eukaryotic Expression Vector

Cloning and Expression of Human Alpha-fetoprotein Gene

Expression and Identification of Human Alpha Fetoprotein in E.coli

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Construction of a Recombinant Eukaryotic Expression Vector Pegfp-Afp-tk and Transfection into Hepatoma Cells by PEG-PEI/Fe_3O_4 Magnetic Nanoparticles

Construction and identification of alpha-fetoprotein antigen epitope modified interleukin-15 lentiviral expression vector

[Construction of Eukaryotic Expression Vector of Mouse Alpha-Fetoprotein Cdna and Its Expression in Dendritic Cells and in Vitro Antitumor Effect on Hepatoma].

Construction of a Recombinant Eukaryotic Vector Expressing Human Tumor Necrosis Factor Alpha

Construction and identification of eukaryotic expression vector of tissue factor pathway inhibitor-2 gene

Construction of a Regulatable Gene Therapy Vector Specific for Hepatocellular Carcinoma

Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma

Construction, Expression and Identification of Anti-human AFP Single Domain Antibody Fusion Protein

Selective Cloning and Recombination of the Murine Alpha-Fetoprotein Cis-Acting Elements and Studies of Their Functions

Construction of a Eukaryotic Expression Vector Hvegf_(165)-Fused Hirudin/pcdna3.0 and Its Expression

Construction of Eukaryotic Expression Vector of Wtp53/junb Fusion Gene

Construction of the eukaryotic expression plasmid containing human epidermal growth factor gene with signal peptide

Construction and Expression of Eucaryotic Expression Vector of Porcine Prothymosin Alpha Gene

Construction and identification of the recombinant prokaryotic expression vector PUC18-HGF

Construction of an AFP enhancer-regulated siRNA expression plasmid vector